Artiva Biotherapeutics (ARTV) EPS (Basic) (2023 - 2026)

Artiva Biotherapeutics (ARTV) posted quarterly EPS (Basic) of -$1.43 for Q1 2026, up 5.76% year-over-year from -$1.35 in Q1 2025, and down 64.59% quarter-over-quarter from -$0.87 in Q4 2025.

Artiva Biotherapeutics (ARTV) EPS (Basic) (2023 - 2026) Analysis & Trends

Artiva Biotherapeutics (ARTV) has reported EPS (Basic) for 4 consecutive years, with -$1.43 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) rose 5.76% year-over-year to -$1.43; the TTM figure through Mar 2026 stood at -$4.72 (up 5.74% YoY), while the FY2025 annual figure was -$3.59, up 34.66% from the prior year.
  • EPS (Basic) declined to -$1.43 in Q1 2026 per ARTV's latest filing, from -$0.87 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $13.92 in Q3 2023 and bottomed at -$34.58 in Q2 2024.
  • Historically, EPS (Basic) has averaged -$6.37 across 4 years, with a median of -$1.65 in 2024.
  • Annual changes were most pronounced in 2024 — EPS (Basic) tumbled 144.78% — and 2025, when it surged 95.64%.
  • Artiva Biotherapeutics' EPS (Basic) stood at -$14.45 in 2023, then soared by 85.74% to -$2.06 in 2024, then surged by 57.96% to -$0.87 in 2025, then plunged by 64.59% to -$1.43 in 2026.
  • Business Quant data shows ARTV's EPS (Basic) at -$1.43 in Q1 2026, -$0.87 in Q4 2025, and -$0.95 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Artiva Biotherapeutics 451.28 Mn 451.28 Mn - -0.92

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.92
Mar 31, 2026 -1.43
Dec 31, 2025 -0.87
Sep 30, 2025 -0.95
Jun 30, 2025 -1.51
Mar 31, 2025 -1.51
Dec 31, 2024 -2.06
Sep 30, 2024 -1.79
Jun 30, 2024 -34.58
Mar 31, 2024 -17.09
Dec 31, 2023 -14.45
Sep 30, 2023 13.92
Jun 30, 2023 -14.13